Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (208)
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Kwo Elizabeth — Director
Shares
4,010
Price
$24.26
Total Value
$97.27K
Shares Held After
14,116
% of Holdings
22.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
9,771
Price
$2.10
Total Value
$20.52K
Shares Held After
2,850,000
% of Holdings
0.3%
BillionToOne, Inc. (BLLN)
ten Bosch John Roderick — SVP of Laboratory Operations
Shares
1,416
Price
$106.61
Total Value
$150.96K
Shares Held After
23,635
% of Holdings
5.7%
Amphastar Pharmaceuticals, Inc. (AMPH)
PETERS WILLIAM J — Director
Shares
4,139
Price
$25.00
Total Value
$103.47K
Shares Held After
168,707
% of Holdings
2.4%
Hinge Health, Inc. (HNGE)
Pursley James — President
Shares
800
Price
$95.10
Total Value
$76.08K
Shares Held After
666,909
% of Holdings
0.1%
Hinge Health, Inc. (HNGE)
Pursley James — President
Shares
23,135
Price
$94.40
Total Value
$2.18M
Shares Held After
667,709
% of Holdings
3.3%
Hinge Health, Inc. (HNGE)
Pursley James — President
Shares
9,065
Price
$93.37
Total Value
$846.38K
Shares Held After
690,844
% of Holdings
1.3%
OnKure Therapeutics, Inc. (OKUR)
Leverone Jason A. — Chief Financial Officer
Shares
302
Price
$2.97
Total Value
$898.21
Shares Held After
18,500
% of Holdings
1.6%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
1,687
Price
$165.49
Total Value
$279.18K
Shares Held After
618,902
% of Holdings
0.3%
GRAIL, Inc. (GRAL)
Freidin Aaron — Chief Financial Officer
Shares
521
Price
$95.00
Total Value
$49.49K
Shares Held After
248,983
% of Holdings
0.2%
Legend Biotech Corp (LEGN)
Santos Carlos E — Chief Financial Officer
Shares
5,430
Price
$9.14
Total Value
$49.63K
Shares Held After
14,246
% of Holdings
27.6%
GRAIL, Inc. (GRAL)
Freidin Aaron — Chief Financial Officer
Shares
1,800
Price
$93.92
Total Value
$169.05K
Shares Held After
249,504
% of Holdings
0.7%
OnKure Therapeutics, Inc. (OKUR)
Saccomano Nicholas A — Director
Shares
87
Price
$2.97
Total Value
$258.76
Shares Held After
11,160
% of Holdings
0.8%
GRAIL, Inc. (GRAL)
Freidin Aaron — Chief Financial Officer
Shares
1,779
Price
$92.26
Total Value
$164.14K
Shares Held After
251,304
% of Holdings
0.7%
Twist Bioscience Corp (TWST)
Green Paula — SVP of Human Resources
Shares
294
Price
$165.49
Total Value
$48.65K
Shares Held After
116,720
% of Holdings
0.3%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
10,000
Price
$110.00
Total Value
$1.10M
Shares Held After
362,271
% of Holdings
2.7%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
2,100
Price
$100.68
Total Value
$211.43K
Shares Held After
372,271
% of Holdings
0.6%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
421
Price
$99.85
Total Value
$42.04K
Shares Held After
374,371
% of Holdings
0.1%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
1,400
Price
$97.84
Total Value
$136.98K
Shares Held After
374,792
% of Holdings
0.4%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
6,200
Price
$96.43
Total Value
$597.87K
Shares Held After
376,192
% of Holdings
1.6%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
37,752
Price
$94.98
Total Value
$3.59M
Shares Held After
382,392
% of Holdings
9.0%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
1,454
Price
$93.61
Total Value
$136.10K
Shares Held After
420,144
% of Holdings
0.3%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
2,125
Price
$92.32
Total Value
$196.17K
Shares Held After
421,598
% of Holdings
0.5%
Twist Bioscience Corp (TWST)
Cho Dennis — Senior Vice President, Chief Legal Officer&Corporate Secretary
Shares
348
Price
$165.49
Total Value
$57.59K
Shares Held After
73,303
% of Holdings
0.5%
REVVITY, INC. (RVTY)
Krakowiak Maxwell — Senior Vice President and Chief Financial Officer
Shares
1,631
Price
$144.53
Total Value
$235.73K
Shares Held After
14,781
% of Holdings
9.9%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
21,883
Price
$623.29
Total Value
$13.64M
Shares Held After
482,390
% of Holdings
4.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
2,718
Price
$35.33
Total Value
$96.04K
Shares Held After
9,550
% of Holdings
22.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
3,198
Price
$35.33
Total Value
$113.00K
Shares Held After
11,236
% of Holdings
22.2%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
8,580
Price
$35.33
Total Value
$303.17K
Shares Held After
21,479
% of Holdings
28.5%
Pharvaris N.V. (PHVS)
Nassif David W. — CFO / CLO
Shares
6,000
Price
$36.47
Total Value
$218.80K
Shares Held After
114,300
% of Holdings
5.0%
SOPHiA GENETICS SA (SOPH)
Muken Ross — Director
Shares
422
Price
$8.33
Total Value
$3.52K
Shares Held After
670,229
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
CARDOZA GEORGE — Chief Financial Officer
Shares
774
Price
$8.33
Total Value
$6.45K
Shares Held After
308,318
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,438
Price
$28.12
Total Value
$209.14K
Shares Held After
38,400
% of Holdings
16.2%
VERACYTE, INC. (VCYT)
Leite John — Global Chief Commercial Off
Shares
4,015
Price
$40.00
Total Value
$160.60K
Shares Held After
124,329
% of Holdings
3.1%
Phreesia, Inc. (PHR)
Hoffman Allison C — General Counsel&Secretary
Shares
6,662
Price
$10.08
Total Value
$67.15K
Shares Held After
266,574
% of Holdings
2.4%
Claritev Corp (CTEV)
Garis Douglas Michael — EVP&CFO
Shares
1,148
Price
$31.19
Total Value
$35.81K
Shares Held After
185,416
% of Holdings
0.6%
Claritev Corp (CTEV)
Garis Douglas Michael — EVP&CFO
Shares
7,877
Price
$30.50
Total Value
$240.27K
Shares Held After
186,564
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
843
Price
$496.62
Total Value
$418.65K
Shares Held After
324,443
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,287
Price
$495.71
Total Value
$1.13M
Shares Held After
325,286
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,170
Price
$494.82
Total Value
$1.07M
Shares Held After
327,573
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,680
Price
$493.60
Total Value
$1.32M
Shares Held After
329,743
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,520
Price
$492.97
Total Value
$749.32K
Shares Held After
332,423
% of Holdings
0.5%
REPLIGEN CORP (RGEN)
Loeillot Olivier — Director
Shares
5,426
Price
$180.00
Total Value
$976.68K
Shares Held After
48,369
% of Holdings
10.1%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
33,000
Price
$97.81
Total Value
$3.23M
Shares Held After
456,209
% of Holdings
6.7%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
533
Price
$95.75
Total Value
$51.03K
Shares Held After
14,219
% of Holdings
3.6%
CYBIN INC. (CYBN)
Halstead Michael — Chief Executive Officer
Shares
100,000
Price
$13.47
Total Value
$1.35M
Shares Held After
168,568
% of Holdings
59.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
2,667
Price
$95.31
Total Value
$254.20K
Shares Held After
29,995
% of Holdings
8.2%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
601
Price
$94.44
Total Value
$56.76K
Shares Held After
32,662
% of Holdings
1.8%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,832
Price
$93.32
Total Value
$357.59K
Shares Held After
33,263
% of Holdings
10.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
2,900
Price
$92.37
Total Value
$267.87K
Shares Held After
37,095
% of Holdings
7.3%
Showing 101–150 of 208 transactions (page 3 of 5)